27.04.2010 • News

Albemarle Q1 Revenue Up 19.3%

Specialty chemicals maker Albemarle Corp posted a better-than-expected first-quarter profit on Monday as earnings jumped in its polymer and catalyst businesses.

For the January-to-March period, the company reported net income of $63.3 million, or 69 cents per share, compared with $25.4 million, or 28 cents per share, in the year-ago period. Excluding restructuring charges, the company posted profit of 74 cents per share.

By that measure, analysts expected earnings of 63 cents per share, according to Thomson Reuters I/B/E/S. The Baton Rouge, La., company said revenue rose 19.3% to $580.3 million. Analysts expected $553.4 million in revenue.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read